CEMIP and cholangiocarcinoma: KIAA1199 levels were high in bile from CCA patients with cholestasis (median: 13.54 ng/ml (range: 3.059-26.39 ng/ml), Figure 3A) and no expression of KIAA1199 was detected in bile of healthy individuals (patients with right hepatic hemangioma or who had undergone cholecystectomy).